Search

Displaying results 8821 - 8830 of 10000 in total
  1. Drug

    Futuximab

    go.drugbank.com/drugs/DB15262
    Investigational

    Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).

  2. Drug

    Epalrestat

    go.drugbank.com/drugs/DB15293
    Investigational

    Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    DU125530

    go.drugbank.com/drugs/DB16040
    Investigational

    DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder).

    Categories: Heterocyclic Compounds, 1-Ring, Serotonin 5-HT1 Receptor Antagonists
  4. Drug

    Dynorphin

    go.drugbank.com/drugs/DB16146
    Investigational

    Dynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction - 1).

    Synonyms: Dynorphin a (1-17), Dynorphin a 1-17
  5. Drug

    GP2 peptide

    go.drugbank.com/drugs/DB16180
    Investigational

    GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).

    Synonyms: Gp-2 her2-derived, hla-a2+ restricted peptide
  6. Drug

    C-peptide

    go.drugbank.com/drugs/DB16187
    Investigational

    C-peptide is under investigation in clinical trial NCT00278980 (Effect of C-peptide on Diabetic Peripheral Neuropathy).

    Synonyms: C-peptide, Human c-peptide
  7. Drug

    Lonaprisan

    go.drugbank.com/drugs/DB16221
    Investigational

    Lonaprisan is under investigation in clinical trial NCT00555919 (ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer).

  8. Drug

    Osalmid

    go.drugbank.com/drugs/DB16273
    Investigational

    Osalmid is under investigation in clinical trial NCT03670173 (Safety and Efficacy Assessments of Osalmid in Multiple Myeloma).

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  9. Drug

    KB109

    go.drugbank.com/drugs/DB16531
    Experimental

    KB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.

  10. Drug

    Volrubigene ralaparvovec

    go.drugbank.com/drugs/DB16785
    Investigational

    Volrubigene ralaparvovec is under investigation in clinical trial NCT03223194 (Gene Transfer Clinical Study in Crigler-najjar Syndrome).

    Synonyms: Non-replicating recombinant adeno-associated viral vector, serotype 8, expressing the 1A1 isoform of the bilirubin-uridine diphosphate glucuronosyltransferase gene